APA (7th ed.) Citation

W, F., E, W., CYC, K., JF, N. d. R. G., C, K., R, K., & BC, W. Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer. Dove Medical Press.

Chicago Style (17th ed.) Citation

W, Furnback, Wu E, Koh CYC, Nino de Rivera Guzman JF, Kruhl C, Kotecha R, and Wang BC. Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer. Dove Medical Press.

MLA (9th ed.) Citation

W, Furnback, et al. Estimating the Cost-Effectiveness of Tumor Treating Fields (TTFields) Therapy with an Immune Checkpoint Inhibitor or Docetaxel in Metastatic Non-Small Cell Lung Cancer. Dove Medical Press.